Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001423898-25-000005
Filing Date
2025-08-13
Accepted
2025-08-13 17:33:26
Documents
1
Period of Report
2025-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1755120803.html 4  
1 FORM 4 wk-form4_1755120803.xml 4 29926
  Complete submission text file 0001423898-25-000005.txt   31472
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 750 BATTERY STREET, SUITE 330 SAN FRANCISCO CA 94111
Business Address
Taub Rebecca (Reporting) CIK: 0001423898 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 251213168